# Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study

> **NCT02005627** · PHASE2 · COMPLETED · sponsor: **Imperial College London** · enrollment: 46 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Grazax
- **DRUG:** Grazax Placebo

## Key facts

- **NCT ID:** NCT02005627
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-01
- **Primary completion:** 2017-03-01
- **Final completion:** 2017-03-01
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2019-12-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02005627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02005627, "Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02005627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*